Additionally, besides triple negative breast cancer cells, FDI-6 also effectively suppressed the growth of FOXM1 expressing ER-positive MCF-7 cells in a dose dependent manner, and the IC50 was 3.227 ± 0.5.3 μM (Figure S1). Here, ESR1 is linked to triple-negative breast carcinoma.